CTOs on the Move

Pulse Biosciences

www.pulsebiosciences.com

 
Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Paul Friedrichs
VP, Electrical and Systems Engineering Profile

Funding

Pulse Biosciences raised $45M on 12/17/2018
Pulse Biosciences raised $30M on 06/16/2020
Pulse Biosciences raised $50M on 07/01/2021

Similar Companies

abc med international sales inc

abc med international sales inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PDI

PDI is dedicated to leading the fight against preventable infections in healthcare, foodservice and our communities. Driven by a commitment to research, quality and service, PDI provides innovative products, educational resources, training and support to help prevent infection transmission and promote health and wellness. PDI has three divisions, PDI Healthcare, Sani Professional® and PDI Contract Manufacturing.

BAROnova

BAROnova, Inc., founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.

Healthcare Logistics

Healthcare Logistics is a Circleville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corindus

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."